This could offset that.......
From an operational perspective, we continue to sell and ship Onko-Sure test kits to the following territories: Korea, Turkey, Taiwan, India,
Vietnam, and the U.S. Despite significant financial hardship, the Company continues to maintain its operations in Tustin, relying on selective
former employees that continue to work as consultants to the Company. We are also engaged in business discussions with other companies
seeking to license Onko-Sure for various international territories. These licensing agreements, if completed, are anticipated to provide the
Company with the funds necessary to regain compliance with our public filing requirements and to begin to pay down various overdue
accounts payable. There can be no guarantee that any new licensing transactions will be completed.
As of October 3, 2012, we had 3,235,210,154 shares of common stock issued and outstanding.
Must be one big deal money wise to be able to do the following.......
These licensing agreements, if completed, are anticipated to provide the
Company with the funds necessary to regain compliance with our public filing requirements and to begin to pay down various overdue
accounts payable.
I'm speculating.... but happy to do so with a buy in of .0001
With more risk comes reward and there is a lot of upside should anything play out with this.
IMO
